Ocular Therapeutix, Inc.
USD10.16
+0.26 (+2.63%)
CEO
Pravin U. Dugel
IPO Date
2014-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.98
Prev. Close
$9.90
Day Low
$9.86
Day High
$10.18
52W Low
$6.23
52W High
$16.44
Market Cap
$2.22B
Volume
0.73M
| -7.0 |
| 31 Dec 2023 | FY | 91.0% | -138.1% | -88.6% | -32.0% | 0.92 | 6.66 | -4.4 |
| 31 Dec 2022 | FY | 91.2% | -138.0% | -200.8% | -47.6% | 1.82 | 4.13 | -3.0 |
| 31 Dec 2021 | FY | 89.9% | -15.1% | -7.4% | -3.2% | 0.67 | 7.26 | -81.3 |
| 31 Dec 2020 | FY | 88.0% | -894.3% | -204.5% | -59.4% | 0.77 | 9.23 | -8.1 |
| 31 Dec 2019 | FY | 45.0% | -2043.3% | 2379.4% | -109.7% | -16.35 | 5.00 | -2.1 |
| 31 Dec 2018 | FY | 76.6% | -2899.1% | -160.8% | -79.0% | 0.69 | 6.14 | -2.6 |
| 31 Dec 2017 | FY | 76.2% | -3296.2% | -242.4% | -114.4% | 0.69 | 3.23 | -2.0 |
| 31 Dec 2016 | FY | 76.5% | -2369.0% | -86.0% | -59.7% | 0.30 | 8.42 | -4.6 |
| -10.5 |
| 30 Sept 2025 | Q3 | 87.8% | -477.3% | -26.9% | -16.9% | 0.30 | 7.85 | -7.7 |
| 30 Jun 2025 | Q2 | 85.6% | -503.9% | -22.2% | -15.0% | 0.25 | 10.09 | -5.9 |
| 31 Mar 2025 | Q1 | 88.2% | -598.7% | -24.1% | -15.8% | 0.29 | 10.22 | -4.8 |
| 31 Dec 2024 | Q4 | 92.8% | -283.3% | -15.3% | -10.6% | 0.24 | 10.66 | -7.4 |
| 30 Sept 2024 | Q3 | 89.9% | -236.6% | -10.4% | -7.4% | 0.21 | 13.01 | -10.0 |
| 30 Jun 2024 | Q2 | 90.8% | -266.3% | -11.6% | -8.5% | 0.20 | 16.64 | -6.3 |
| 31 Mar 2024 | Q1 | 91.0% | -438.9% | -15.9% | -12.0% | 0.18 | 21.39 | -4.4 |
| 31 Dec 2023 | Q4 | 90.6% | -197.4% | -32.1% | -11.6% | 0.92 | 6.66 | -4.0 |